On the contrary, EPB41L4A-AS1, previously described as a tumor suppressor [34], resulted downregulated in tumor tissues and in BC cells, compared to normal ones, while PVT1, previously described as a pan-oncogene [35–37], resulted overexpressed in both. This evidence concerns the gene PVT1 and breast cancer.